Method and device for high field strength electrotransfection of microvesicles and cells

The USPTO issued Patent US12594556B2 to The Charles Stark Draper Laboratory, Inc. for a device, system, and process involving electroporation of microvesicles, exosomes, or other target structures in a microfluidic arrangement operating at pressures exceeding atmospheric pressure. The technology supports single and multiple flow configurations with computer-controlled partial or complete automation. The patent contains 18 claims and was filed on November 21, 2023, under application number 18515386.

Patent grants are informational notices establishing intellectual property rights and do not impose compliance deadlines, required actions, or penalties. Technology companies, pharmaceutical manufacturers, and medical device developers working in electroporation, gene delivery, or exosome manipulation should review the claims to assess potential freedom-to-operate implications or licensing opportunities. No immediate regulatory action is required.